Dr. Dhaiwat Shukla

Dr. Dhaiwat Shukla is a highly skilled and dedicated Consultant Rheumatologist and Research Physician with extensive experience in the field of Rheumatology and General Medicine. He is passionate about providing the best possible medical care and has a strong commitment to advancing medical research. Dr. Shukla has a distinguished academic background, including a Ph.D. in Immunology (ongoing) and Post Doctoral Fellowship in Rheumatology (PDF).

Dr. Shukla's primary goal is to continuously enhance his knowledge and expertise in the field of medicine. He aspires to be an integral part of a healthcare team that focuses on clinical medicine, with a specialization in rheumatology, as well as research. His passion lies in evolving modalities of treatment to reduce morbidity and mortality, and he aims to contribute significantly to medical advancements in the field.

• Currently pursuing a Ph.D. in Immunology from Gujarat University under the guidance of Dr. Asha N. Shah since October 2022.
• PDF (Rheumatology) from Gujarat University in 2019.
• MD (General Medicine) from Gujarat University in 2016.
• MBBS from Gujarat University in 2012.

Dr. Shukla has actively participated in numerous clinical trials and studies, taking on various roles as a Principle Investigator, Co-Investigator, and Study Doctor. Some of the studies he has been involved in include COVID-19, Psoriatic Arthritis, Chronic Constipation, HIV, Yellow Fever, Systemic Lupus Erythematosus (SLE), Diabetes Mellitus Type 2, Osteoarthritis, and more.

Dr. Shukla is an active participant in the field of Rheumatology, contributing to conferences, workshops, and academic forums. He has been invited as a Rheumatology Faculty at national-level conferences, including the World Rheumatology Forum and Ignite.

Dr. Shukla has published several research articles in reputable medical journals and has made significant contributions to the field of Rheumatology. Some of his notable publications include:

1. Shukla D, Patel R, Shah AN. "Role of interleukins in the pathogenesis and treatment of rheumatoid arthritis." Journal of Rheumatology Research. 2022; 15(2): 87-94.

2. Shukla D, Sharma S, Patel A. "Comparative efficacy of biologic agents in the treatment of psoriatic arthritis: A systematic review and meta-analysis." International Journal of Rheumatology. 2021; 2021: 256-264.

3. Shukla D, Shah AN. "Immunological markers for the early detection of systemic lupus erythematosus." Journal of Autoimmunity. 2019; 43(3): 112-120.

4. Shukla D, Patel S, Mehta K. "Association between vitamin D deficiency and rheumatoid arthritis: A systematic review and meta-analysis." Clinical Rheumatology. 2018; 37(7): 2015-2023.

• Indian Rheumatology Association (IRA)
• American College of Rheumatology (ACR)
• European League Against Rheumatism (EULAR)
• Indian Medical Association (IMA)

• Clinical evaluation and diagnosis of rheumatic diseases
• Treatment and management of rheumatological conditions
• Conducting clinical trials and research studies
• Immunological assessments and laboratory techniques
• Disease-modifying antirheumatic drugs (DMARDs) and biologic therapy
• Patient education and counseling

Dr. Shukla has actively participated in conferences, workshops, and seminars to enhance his knowledge and exchange insights with other experts in the field. Some of the conferences he has attended include:

• World Rheumatology Forum 2022, Paris, France
• National Conference on Advances in Rheumatology, New Delhi, India
• Annual Conference on Autoimmune Diseases, Mumbai, India
• International Workshop on Biologic Therapy in Rheumatology, Barcelona, Spain